𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cost-utility analysis of treatment strategies in patients with recent-onset rheumatoid arthritis

✍ Scribed by Van den Hout, Wilbert B. ;Goekoop-Ruiterman, Yvonne P. M. ;Allaart, Cornelia F. ;De Vries-Bouwstra, Jeska K. ;M. Hazes, J. Mieke ;Kerstens, Pit J. S. M. ;Van Zeben, Derkjen ;Hulsmans, Harry M. J. ;De Jonge-Bok, Johanna M. ;De Sonnaville, Peter B. J. ;Dijkmans, Ben A. C. ;Breedveld, Ferdinand C.


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
120 KB
Volume
61
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Patient-reported outcomes in a randomize
✍ van der Kooij, S. M. ;de Vries-Bouwstra, J. K. ;Goekoop-Ruiterman, Y. P. M. ;Ewa πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 204 KB πŸ‘ 2 views

## Abstract ## Objective To investigate the effectiveness of 4 different treatment strategies for recent‐onset rheumatoid arthritis (RA) on 2‐year patient‐reported outcomes, including functioning and quality of life. ## Methods A total of 508 patients with recent‐onset RA were randomly assigned

A cost-effectiveness analysis of treatme
✍ Hyon K. Choi; John D. Seeger; Karen M. Kuntz πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 106 KB πŸ‘ 2 views

## Objective: Recently, new treatment options for rheumatoid arthritis (ra) patients with an inadequate response to methotrexate (mtx) have become available. given the wide variability in efficacy and costs among these different treatment options, we sought to determine their cost-effectiveness (ce

Relationship between genetic variants in
✍ Judith A. M. Wessels; Wouter M. Kooloos; Robert De Jonge; Jeska K. De Vries-Bouw πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 187 KB πŸ‘ 1 views

## Abstract ## Objective Among patients with rheumatoid arthritis (RA), there is a high degree of interindividual variability in the degree of response to methotrexate (MTX) treatment. This study was undertaken to explore polymorphisms in genes contributing to antiinflammatory adenosine release as